Remifentanil: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Remifentanil. Educational only — not medical advice.

Labeled uses

Remifentanil hydrochloride (HCl) for injection is indicated for intravenous (IV) administration: • As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. • For continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. • As an analgesic component of monitored anesthesia care in adult patients.

Source: FDA labeling via NIH DailyMed (set d2374b84…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.